The market for smart syringes is a vital part of the healthcare industry and is anticipated to develop at a CAGR of 11.5% between 2023 and 2031. Concerns over needlestick injuries, vaccination programmes, and advances in drug delivery technologies propel the market. Cost remains a barrier, necessitating concerted efforts to improve affordability. Key players will likely prioritise safety, innovation, and ...
Read More »